Literature DB >> 16720982

Lack of long-term protective effect of antioxidant/anti-inflammatory therapy in transplant-induced ischemia/reperfusion injury.

You-Lin Tain1, Veronika Muller, Attila Szabo, Anna Dikalova, Kathy Griendling, Chris Baylis.   

Abstract

BACKGROUND: Alloantigen-independent factors contribute to long-term damage in renal transplant recipients, likely due to ischemia/reperfusion (I/R) injury at transplantation (Tx). I/R injury promotes oxidative stress and inflammation resulting in endothelial injury.
METHODS: In this study we investigated the long-term efficacy (22 weeks) of short-term (10 day) endothelial protection therapy (EP) in 'optimal' donor kidneys using the male Fisher 344 rat isograft (ISO) model. ISO-EP kidneys were compared to untreated ISO (ISO-UN) kidneys. EP involved dexamethasone to donor, ex vivo treatment of the kidney with deferoxamine and tempol, and administration to the recipient of L-arginine and tempol for 10 days. Rats were sacrificed 22 weeks following Tx and compared to age-matched, normal controls.
RESULTS: Both groups of ISO Tx rats developed similar renal dysfunction and structural damage and renal NADPH-oxidase-dependent O2- production was similarly elevated in ISO-UN and ISO-EP groups vs. controls. In vitro renal cortex NO synthase (NOS) activity was also similar in ISO-UN and ISO-EP rats, despite lower nNOS and eNOS protein abundance in ISO-EP.
CONCLUSION: I/R injury-induced late graft dysfunction occurs even when optimal donors are used and when short-term EP treatment is given. Increased renal superoxide production is not prevented by short-term EP therapy. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16720982      PMCID: PMC2756816          DOI: 10.1159/000093587

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  15 in total

1.  L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation.

Authors:  Lothar Schramm; Mylinh La; Ekkehart Heidbreder; Markus Hecker; Joe S Beckman; Kai Lopau; Josef Zimmermann; Johann Rendl; Christoph Reiners; Sabine Winderl; Christoph Wanner; Harald H H W Schmidt
Journal:  Kidney Int       Date:  2002-04       Impact factor: 10.612

2.  Renal protective effect of molsidomine and L-arginine in ischemia-reperfusion induced injury in rats.

Authors:  Vikas Chander; Kanwaljit Chopra
Journal:  J Surg Res       Date:  2005-09       Impact factor: 2.192

3.  Improved graft survival after renal transplantation in the United States, 1988 to 1996.

Authors:  S Hariharan; C P Johnson; B A Bresnahan; S E Taranto; M J McIntosh; D Stablein
Journal:  N Engl J Med       Date:  2000-03-02       Impact factor: 91.245

Review 4.  Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury.

Authors:  S Cuzzocrea; D P Riley; A P Caputi; D Salvemini
Journal:  Pharmacol Rev       Date:  2001-03       Impact factor: 25.468

5.  Protection of wistar furth rats from chronic renal disease is associated with maintained renal nitric oxide synthase.

Authors:  Aaron Erdely; Laszlo Wagner; Veronica Muller; Attila Szabo; Chris Baylis
Journal:  J Am Soc Nephrol       Date:  2003-10       Impact factor: 10.121

6.  Functional association of nox1 with p22phox in vascular smooth muscle cells.

Authors:  Ibrahim R Hanna; Lula L Hilenski; Anna Dikalova; Yoshihiro Taniyama; Sergey Dikalov; Alicia Lyle; Mark T Quinn; Bernard Lassègue; Kathy K Griendling
Journal:  Free Radic Biol Med       Date:  2004-11-15       Impact factor: 7.376

7.  Noninvasive diagnostic tool for inflammation-induced oxidative stress using electron spin resonance spectroscopy and an extracellular cyclic hydroxylamine.

Authors:  Sergey I Dikalov; Anna E Dikalova; Ronald P Mason
Journal:  Arch Biochem Biophys       Date:  2002-06-15       Impact factor: 4.013

8.  Short-term immunosuppressive treatment of the donor ameliorates consequences of ischemia/ reperfusion injury and long-term graft function in renal allografts from older donors.

Authors:  Anja Reutzel-Selke; Thomas Zschockelt; Christian Denecke; Ulrike Bachmann; Anke Jurisch; Johann Pratschke; Georg Schmidbauer; Hans-Dieter Volk; Peter Neuhaus; Stefan G Tullius
Journal:  Transplantation       Date:  2003-06-15       Impact factor: 4.939

9.  Renal neuronal nitric oxide synthase protein expression as a marker of renal injury.

Authors:  Attila J Szabo; Laszlo Wagner; Aaron Erdely; Kim Lau; Chris Baylis
Journal:  Kidney Int       Date:  2003-11       Impact factor: 10.612

10.  Deferoxamine reduces cold-ischemic renal injury in a syngeneic kidney transplant model.

Authors:  Hong Huang; Zhi He; L Jackson Roberts; Abdulla K Salahudeen
Journal:  Am J Transplant       Date:  2003-12       Impact factor: 8.086

View more
  5 in total

1.  Mechanisms of sphingosine-1-phosphate-mediated vasoconstriction of rat afferent arterioles.

Authors:  Z Guan; F Wang; X Cui; E W Inscho
Journal:  Acta Physiol (Oxf)       Date:  2017-07-13       Impact factor: 6.311

2.  Sex differences in response to cyclosporine immunosuppression in experimental kidney transplantation.

Authors:  Veronika Muller; Attila J Szabo; Aaron Erdely; You-Lin Tain; Chris Baylis
Journal:  Clin Exp Pharmacol Physiol       Date:  2007-12-07       Impact factor: 2.557

Review 3.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

4.  Renal cortex neuronal nitric oxide synthase in response to rapamycin in kidney transplantation.

Authors:  You-Lin Tain; Veronika Muller; Attila J Szabo; Aaron Erdely; Cheryl Smith; Chris Baylis
Journal:  Nitric Oxide       Date:  2007-10-12       Impact factor: 4.427

Review 5.  Taking up the cudgels for the traditional reactive oxygen and nitrogen species detection assays and their use in the cardiovascular system.

Authors:  Andreas Daiber; Matthias Oelze; Sebastian Steven; Swenja Kröller-Schön; Thomas Münzel
Journal:  Redox Biol       Date:  2017-02-07       Impact factor: 11.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.